Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Positive Expression of Human Cytomegalovirus Phosphoprotein 65 in Atherosclerosis.

Wang Z, Cai J, Zhang M, Wang X, Chi H, Feng H, Yang X.

Biomed Res Int. 2016;2016:4067685. Epub 2016 Nov 20.

2.

Myopericarditis complicated by pulmonary embolism in an immunocompetent patient with acute cytomegalovirus infection: a case report.

Vandamme YM, Ducancelle A, Biere L, Viot N, Rouleau F, Delbos V, Abgueguen P.

BMC Res Notes. 2014 Mar 28;7:193. doi: 10.1186/1756-0500-7-193.

3.

Small-bowel necrosis complicating a cytomegalovirus-induced superior mesenteric vein thrombosis in an immunocompetent patient: a case report.

Kalaitzis J, Basioukas P, Karzi E, Markakis C, Liarmakopoulos E, Hadjimarkou A, Rizos S.

J Med Case Rep. 2012 Apr 24;6:118. doi: 10.1186/1752-1947-6-118.

4.

Is human cytomegalovirus a target in cancer therapy?

Johnsen JI, Baryawno N, Söderberg-Nauclér C.

Oncotarget. 2011 Dec;2(12):1329-38. Review.

5.

The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses.

Paulus C, Nevels M.

Viruses. 2009 Dec;1(3):760-79. doi: 10.3390/v1030760. Epub 2009 Nov 5.

6.

Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Schleiss MR.

Infect Disord Drug Targets. 2011 Oct;11(5):449-65. Review.

7.

Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Hwang ES, Zhang Z, Cai H, Huang DY, Huong SM, Cha CY, Huang ES.

J Virol. 2009 Dec;83(23):12388-98. doi: 10.1128/JVI.00304-09. Epub 2009 Sep 23.

8.

The story of human cytomegalovirus and cancer: increasing evidence and open questions.

Michaelis M, Doerr HW, Cinatl J.

Neoplasia. 2009 Jan;11(1):1-9. Review.

10.

Human cytomegalovirus UL38 protein blocks apoptosis.

Terhune S, Torigoi E, Moorman N, Silva M, Qian Z, Shenk T, Yu D.

J Virol. 2007 Apr;81(7):3109-23. Epub 2007 Jan 3.

12.

Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Castillo JP, Frame FM, Rogoff HA, Pickering MT, Yurochko AD, Kowalik TF.

J Virol. 2005 Sep;79(17):11467-75.

13.
14.

The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.

Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S.

J Virol. 2002 Dec;76(24):12503-12.

15.

Role of human cytomegalovirus immediate-early proteins in cell growth control.

Castillo JP, Yurochko AD, Kowalik TF.

J Virol. 2000 Sep;74(17):8028-37.

Supplemental Content

Support Center